Serological identification of human tumor antigens (Q41642426)

6 October 2017

1 reference

title

Serological identification of human tumor antigens (English)

1 reference

6 October 2017

1 reference

6 October 2017

Pfreundschuh M

1 reference

6 October 2017

Türeci O

1 reference

6 October 2017

publication date

1 October 1997

1 reference

Current Opinion in Immunology

6 October 2017

published in

1 reference

6 October 2017

1 reference

6 October 2017

1 reference

6 October 2017

page(s)

709-716

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Do human cancers express shared protective antigens? or the necessity of remembrance of things past

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Serological analysis of cell surface antigens of malignant human brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Cell surface antigens of human renal cancer defined by autologous typing

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Detection of tumor antigens with monoclonal antibodies: immunopathology and immunodiagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

1975-1995 revised anti-cancer serological response: biological significance and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Presence of circulating anti-c-myb oncogene product antibodies in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Serological analysis of human tumor antigens: molecular definition and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

T cell activation determined by T cell receptor number and tunable thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

PCM-1, A 228-kD centrosome autoantigen with a distinct cell cycle distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Harnessing self-reactivity in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Is cancer dangerous to the immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Synaptonemal complex proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Gene expression, X-inactivation, and methylation during spermatogenesis: the case of Zfa, Zfx, and Zfy in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Selective events in T cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Negative selection of lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Antibodies against p53 are associated with poor prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Characterisation and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Oncogenic proteins as tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Serum p53 antibodies as early markers of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Peptide-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Anti-tyrosinase antibodies in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

p53, a potential target for tumor-directed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

T cell-mediated cytotoxicity against p53-protein derived peptides in bulk and limiting dilution cultures of healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980053-2

7 January 2021

10.1016/S0952-7915(97)80053-2

Identifiers

DOI

1 reference

6 October 2017

1 reference